Characteristic | Model for risk of ED attendance for acute hypoglycemiaa | Model for risk of hospitalization after an ED attendanceb | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Negative binomial component | Zero inflate component | ||||||||||||
IRR | 95%CI | P value | OR | 95%CI | P value | IRR | 95%CI | P value | |||||
Gender | Female vs. male | 1.51 | 1.18 | 1.93 | 0.001 | 1.16 | 0.75 | 1.80 | 0.500 | 1.06 | 0.85 | 1.33 | 0.589 |
Age class (years) | ref., 45–64 |  |  |  |  |  |  |  |  |  |  |  |  |
≤ 44 | 0.86 | 0.40 | 1.84 | 0.693 | 0.54 | 0.24 | 1.22 | 0.139 | 0.98 | 0.69 | 1.39 | 0.902 | |
≥ 65 | 0.24 | 0.12 | 0.52 | < 0.001 | 0.22 | 0.08 | 0.57 | 0.002 | 1.02 | 0.79 | 1.32 | 0.893 | |
Deprivation index | ref., I-II | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
III | 0.80 | 0.58 | 1.12 | 0.195 | 0.70 | 0.38 | 1.28 | 0.247 | 1.03 | 0.76 | 1.41 | 0.849 | |
IV-V | 0.91 | 0.68 | 1.21 | 0.504 | 0.64 | 0.38 | 1.07 | 0.092 | 0.86 | 0.65 | 1.12 | 0.260 | |
Hypoglycemia treatment | ref., Other non-insulin anti-DM drugs only | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Insulin alone | 7.72 | 5.11 | 11.66 | < 0.001 | 0.56 | 0.28 | 1.12 | 0.099 | 2.00 | 1.31 | 3.05 | 0.001 | |
Insulin and non-insulin anti-DM drugs | 8.01 | 5.21 | 12.32 | < 0.001 | 0.58 | 0.28 | 1.22 | 0.150 | 1.36 | 0.88 | 2.11 | 0.170 | |
Anti-DM drugs at risk of hypoglycemia | 1.88 | 1.22 | 2.89 | 0.004 | 0.78 | 0.36 | 1.67 | 0.521 | 1.16 | 0.72 | 1.87 | 0.552 | |
Glycated hemoglobin test | No vs. yes | 1.36 | 1.07 | 1.72 | 0.012 | 0.65 | 0.42 | 0.99 | 0.044 | 1.37 | 1.10 | 1.72 | 0.006 |
ED attendance for hyperglycemia in 2014 | Yes vs. no | 3.68 | 1.33 | 10.23 | 0.012 | 0.05 | 0.00 | 61.65 | 0.413 | 1.56 | 0.93 | 2.63 | 0.094 |